Get the app
US › Healthcare

Alaunos Therapeutics Inc (TCRT)

US · Healthcare · Biotechnology

$2.63+20.64%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-952,000
EPS
$-0.41

Key statistics

Market cap
$11.4M
Forward P/E
18.5
P/B
4.60
Book value
$0.26
EPS (TTM)
$-1.76
52-week high
$4.50
52-week low
$0.72
50-day MA
$1.51
200-day MA
$2.38
Beta
-0.87

Analyst view

with an average price target of $1.75.

Shareholding

Insiders
16.32%
Institutions
4.23%

Largest institutional holders

FundStake
BlackRock Inc0.73%
Geode Capital Management, LLC0.66%
Vanguard Fiduciary Trust Co0.53%
Vanguard Capital Management, LLC0.48%
Citadel Advisors Llc0.41%
Advisor Group Holdings, Inc.0.06%
Tower Research Capital LLC0.06%
SRS Capital Advisors Inc0.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alaunos Therapeutics Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.